Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development

Biofouling

Volumn 30, Issue 1, 2014, Pages 17-28

  Sambanthamoorthy, Karthik ^a   Luo, Chunyuan ^a   Pattabiraman, Nagarajan ^b   Feng, Xiarong ^a   Koestler, Benjamin ^c   Waters, Christopher M ^c   Palys, Thomas J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Molbox   (United States)

^c Michigan State University ^*  (United States)

Author keywords

Acinetobacter; anti infective; biofilm; c di GMP; Pseudomonas; small molecule antagonist

Indexed keywords

BIOFILM; ENZYME; GOVERNMENT; PATHOGEN; RESEARCH; VIRULENCE;

UNITED STATES;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); EUKARYOTA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

CYCLIC GMP; DIGUANYLATE CYCLASE; ESCHERICHIA COLI PROTEIN; LYASE;

ACINETOBACTER BAUMANNII; ARTICLE; BIOFILM; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG EFFECT; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR LIBRARY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

ACINETOBACTER BAUMANNII; BIOFILMS; COMPUTER SIMULATION; CYCLIC GMP; ESCHERICHIA COLI PROTEINS; HEK293 CELLS; HUMANS; PHOSPHORUS-OXYGEN LYASES; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES;

EID: 84891741030     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2013.832224     Document Type: Article

References (48)

1. Anderl JN, Franklin MJ, Stewart PS. 2000. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 44:1818-1824.
2. Antoniani D, Bocci P, Maciag A, Raffaelli N, Landini P. 2010. Monitoring of di-guanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Appl Microbiol Biotechnol. 85:1095-1104.
3. Bobrov AG, Kirillina O, Ryjenkov DA, Waters CM, Price PA, Fetherston JD, Mack D, Goldman WE, Gomelsky M, Perry RD. 2011. Systematic analysis of cyclic di-GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis. Mol Microbiol. 79:533-551.
4. Chauhan A, Lebeaux D, Ghigo JM, Beloin C. 2012. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother. 56:6310-6318.
5. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu Rev Microbiol. 49:711-745.
6. Cotter PA, Stibitz S. 2007. c-di-GMP-mediated regulation of virulence and biofilm formation. Curr Opin Microbiol. 10:17-23.
7. Dallo SF, Weitao T. 2010. Insights into Acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care. 23:169-174.
8. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discovery. 2:114-122.
9. De N, Pirruccello M, Krasteva PV, Bae N, Raghavan RV, Sondermann H. 2008. Phosphorylation-independent regulation of the diguanylate cyclase WspR. PLoS Biol. 6: e67.
10. Dow JM, Fouhy Y, Lucey JF, Ryan RP. 2006. The HD-GYP domain, cyclic di-GMP signaling, and bacterial virulence to plants. Mol Plant Microbe Interact. 19:1378-1384.
11. Edmunds AC, Castiblanco LF, Sundin GW, Waters CM. 2013. Cyclic di-GMP modulates the disease progression of Erwinia amylovora. J Bacteriol. 195:2155-2165.
12. Fux CA, Costerton JW, Stewart PS, Stoodley P. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40.
13. Galperin MY. 2004. Bacterial signal transduction network in a genomic perspective. Environ Microbiol. 6:552-567.
14. Gjermansen M, Ragas P, Sternberg C, Molin S, Nielsen T. 2005. Characterization of starvation-induced dispersion Pseudomonas putida biofilms. Environ Microbiol. 7:894-906.
15. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2:95-108.
16. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, et al. 2006. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 296:202-211.
17. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell Microbiol. 11:1034-1043.
18. Harrison JJ, Turner RJ, Ceri H. 2005. High-throughput metal susceptibility testing of microbial biofilms. BMC Microbiol. 5:53-64.
19. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 21:26-59.
20. Jenal U, Malone J. 2006. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu Rev Genet. 40:385-407.
21. Jeys L, Grimer R. 2009. The long-term risks of infection and amputation with limb salvage surgery using endoprostheses. Recent Results Cancer Res. 179:75-84.
22. Lipinski CA, Lombardo F, Dominy BW, Freeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 23:3-25.
23. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature. 426:306-310.
24. Monds RD, Newell PD, Gross RH, O'Toole GA. 2007. Phosphate-dependent modulation of c-di-GMP levels Pseudomonas fluorescens Pf0-1 biofilm formation of the adhesin LapA. Mol Microbiol. 63:656-679.
25. Morgan R, Kohn S, Hwang SH, Hassett DJ. 2006. BdlA, a chemotaxis regulator essential for biofilm dispersion Pseudomonas aeruginosa. J Bacteriol. 188:7335-7343.
26. Murphy RA, Ronat JB, Fakhri RM, Herard P, Blackwell N, Abgrall S, Anderson DJ. 2011. Multidrug-resistant chronic osteomyelitis complicating war injury in Iraqi civilians. J Trauma. 71:252-254.
27. Navarro MV, De N, Bae N, Wang Q, Sondermann H. 2009. Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX. Structure. 17:1104-1116.
28. Newell PD, Monds RD, O'Toole GA. 2009. LapD is a bis-(3′,5′)-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0-1. Proc Nat Acad Sci USA. 106:3461-3466.
29. Newell PD, Yoshioka S, Hvorecny KL, Monds RD, O'Toole GA. 2011. A systematic analysis of diguanylate cyclases that promote biofilm formation by Pseudomonas fluorescens Pf0-1. J Bacteriol.193:4685-4698.
30. Rao F, Pasunooti S, Ng Y, Zhuo W, Lim L, Liu AW, Liang ZX. 2009. Enzymatic synthesis of c-di-GMP using a thermophilic diguanylate cyclase. Anal Biochem. 389:138-142.
31. Romling U, Gomelsky M, Galperin MY. 2005. C-di-GMP: the dawning of a novel bacterial signalling system. Mol Microbiol. 57:629-639.
32. Ryan RP, Fouhy Y, Lucey JF, Dow JM. 2006. Cyclic di-GMP signaling in bacteria: recent advances and new puzzles. J Bacteriol. 188:8327-8334.
33. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. 2005. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J Bacteriol. 187:1792-1798.
34. Sambanthamoorthy K, Schwartz A, Nagarajan V, Elasri MO. 2008. The role of msa in Staphylococcus aureus biofilm formation. BMC Microbiol. 8:221-229.
35. Sambanthamoorthy K, Sloup RE, Parashar V, Smith JM, Kim EE, Semmelhack MF, Neiditch MB, Waters CM. 2012. Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob Agents Chemother. 56:5202-5211.
36. Schleheck D, Barraud N, Klebensberger J, Webb JS, McDougald D, Rice SA, Kjelleberg S. 2009. Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLoS ONE. 4:e5513.
37. Schmidt AJ, Ryjenkov DA, Gomelsky M. 2005. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J Bacteriol. 187:4774-4781.
38. Simm R, Fetherston JD, Kader A, Romling U, Perry RD. 2005. Phenotypic convergence mediated by GGDEF-domain-containing proteins. J Bacteriol. 187:6816-6823.
39. Simm R, Morr M, Kader A, Nimtz M, Römling U. 2004. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol Microbiol. 53:1123-1134.
40. Sloan GP, Love CF, Sukumar N, Mishra M, Deora R. 2007. The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J Bacteriol. 189:8270-8276.
41. Stahlhut SG, Struve C, Krogfelt KA, Reisner A. 2012. Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol. 65:350-359.
42. Stoodley P, Braxton E, Nistico L, Hall-Stoodley L, Johnson S, Quigley M, Post JC, Ehrlich GD, Kathju S. 2010. Direct demonstration of Staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure. Pediatr Neurosurg. 46:127-132.
43. Stoodley P, Nistico L, Johnson S, Carabin LA, Baratz M, Gahlot V, Ehrlich GD, Kathju S. 2008. Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty: a case report. J Bone Joint Surg Am. 90:1751-1758.10.2106/JBJS.G.00838
44. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 406:959-964.
45. Tamayo R, Pratt JT, Camilli A. 2007. Role of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu Rev Microbiol. 61:131-148.
46. Trautner BW, Darouiche RO. 2004. Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control. 32:177-183.
47. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE. 2010. Chronic wounds and the medical biofilm paradigm. J Wound Care. 19:45-46, 48-50, 52-53.
48. Zurawski DV, Thompson MG, McQueary CN, Matalka MN, Sahl JW, Craft DW, Rasko DA. 2012. Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis. J Bacteriol. 194:1619-1620.